Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Glareh, Azadi"'
Autor:
Peter Bloomingdale, Daniela Bumbaca-Yadav, Jonathan Sugam, Steve Grauer, Brad Smith, Svetlana Antonenko, Michael Judo, Glareh Azadi, Ka Lai Yee
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Disrupted tau proteostasis and transneuronal spread is a pathological hallmark of Alzheimer’s disease. Neurodegenerative diseases remain an unmet medical need and novel disease modifying therapeutics are paramount. Our objective was to develop a me
Externí odkaz:
https://doaj.org/article/1cfec642604740da9fcf5e195779db1f
Autor:
Daniel M. Gorman, Ming-Tain Lai, Carolyn McHale, Meiqing Lu, Don Graham, Julie Strizki, Yanyan Zheng, Shirley Ma, Soha Moltagh, Marc Bailly, SuChun Hseih, Glareh Azadi, Yaoli Song, Fernando Ugarte, Romina Riener, Wendy Blumenschein, Daria Hazuda, Jeffery Nordstrom, Bonnie Howell
Publikováno v:
Journal of Virus Eradication, Vol 5, Iss , Pp 22- (2019)
Externí odkaz:
https://doaj.org/article/f2198540a84f48a28c4ad2e3cd169728
Autor:
Soha Moltagh, Glareh Azadi, Shirley Ma, Julie Strizki, Bonnie J. Howell, Ming-Tain Lai, Don Graham, Jeffery Nordstrom, Daria J. Hazuda, Meiqing Lu, Carolyn McHale, Romina Riener, Daniel M. Gorman, Fernando Ugarte, Yaoli Song, Marc Bailly, Wendy M. Blumenschein, SuChun Hseih, Yanyan Zheng
Publikováno v:
Journal of Virus Eradication, Vol 5, Iss, Pp 22-(2019)
Publikováno v:
The AAPS journal. 20(4)
With the recent advances in cancer immunotherapy, it is now evident that the antigen-specific activation of the patients' immune responses can be utilized for achieving significant therapeutic benefits. Novel molecules have been developed and promisi
Application of Proof-of-Mechanism Biomarkers (POM) in Design and Development of Biologics Modalities
Publikováno v:
Development of Antibody-Based Therapeutics ISBN: 9789811304958
A science-based approach for translation of exposure–response data is vital for effective advancement of antibody-based therapeutics. A critical consideration during the development of antibody-based therapeutics is selection and evaluation of rele
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ddd45ea766ccc94b0fe9fb1cc4a55f0c
https://doi.org/10.1007/978-981-13-0496-5_9
https://doi.org/10.1007/978-981-13-0496-5_9
Publikováno v:
Protein Science. 22:1258-1265
Dilution of protein-surfactant complexes is an integrated step in microfluidic protein sizing, where the contribution of free micelles to the overall fluorescence is reduced by dilution. This process can be further improved by establishing an optimum
Autor:
Glareh Azadi, Anubhav Tripathi
Publikováno v:
ELECTROPHORESIS. 33:2094-2101
Control of EOF in microfluidic devices is essential in applications such as protein/DNA sizing and high-throughput drug screening. With the growing popularity of poly(methyl methacrylate) (PMMA) as the substrate for polymeric-based microfludics, it i
Publikováno v:
Protein science : a publication of the Protein Society. 22(9)
Dilution of protein–surfactant complexes is an integrated step in microfluidic protein sizing, where the contribution of free micelles to the overall fluorescence is reduced by dilution. This process can be further improved by establishing an optim
Publikováno v:
Applied biochemistry and biotechnology. 168(3)
Techniques to inhibit gram-negative bacteria such as Shiga toxin-producing Escherichia coli are valuable as the prevalence of large-scale industrial food preparation increases the likelihood of contamination. Chitosan, the deacetylated derivative of
Publikováno v:
Biotechnology journal. 7(8)
Conventional immunoblotting techniques are labor intensive, time consuming and rely on the elution of target protein after depletion. Here we describe a new method for detection and quantification of proteins, independent of washing and elution. In t